Julie Gralow: Share your voice to FDA Oncology’s Project 5 in 5 crowdsourcing initiative
Julie Gralow shared a post on X:
“Share your voice to FDA Oncology‘s Project 5 in 5 crowdsourcing initiative – seeking ideas to identify 5 clinically relevant questions using FDA-approved oncology therapies that can be answered through pragmatic clinical trials over the next 5 years.”
Additional details.
Source: Julie Gralow/X
Julie Gralow is the Chief Medical Officer (CMO) and Executive Vice President of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN). Dr. Gralow received the ASCO Humanitarian Award in 2018 for her work in empowering women cancer patients and survivors globally.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023